Dual-drug RGD conjugates provide enhanced cytotoxicity of melanoma and non-small lung cancer cells
Bio-Labile Peptidyl Delivery Systems Towards Sequential Drug Release
Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery
Synthesis, drug release and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety
Papers in Press
‘’Exploiting Fluorescein Based Drug Conjugates for Fluorescent Monitoring in Drug Delivery’’
A. Bazylevich, L. D. Patsenker G. Gellerman, Dyes and Pigments 2017, 139, 460-472.